GSK-1070916

Item number	Size	Delivery time	Price
TGM-T6129-1mg	1 mg	7 - 10 business days*	39.00€
TGM-T6129-5mg	5 mg	7 - 10 business days*	90.00€
TGM-T6129-1mL	1 ml	7 - 10 business days*	102.00€
TGM-T6129-10mg	10 mg	7 - 10 business days*	152.00€
TGM-T6129-25mg	25 mg	7 - 10 business days*	262.00€
TGM-T6129-50mg	50 mg	7 - 10 business days*	413.00€
TGM-T6129-100mg	100 mg	7 - 10 business days*	613.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora... more

Close menu

Product information "GSK-1070916"

Description: GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1. Target: FLT, Apoptosis, Aurora Kinase, Tie-2, AMPK. Smiles: CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1. References: Anderson K, et al. Biochem J, 2009, 420(2), 259-265.

Keywords:	GSK-1070916A, GSK1070916
Supplier:	TargetMol
Supplier-Nr:	T6129

Properties

Application:	Aurora B/C kinase inhibitor
MW:	507.63 D
Formula:	C30H33N7O

Database Information

CAS :	942918-07-2\| Matching products
KEGG ID :	K11479 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "GSK-1070916"

Write a review